Le Lézard
Classified in: Health
Subjects: PER, SCZ

Anne Kempsell Appointed VP of Sales & Marketing at Lutheran Social Ministries of Maryland


WESTMINSTER, Md., June 24, 2020 /PRNewswire/ -- Lutheran Social Ministries of Maryland Inc. (LSMMD) named Anne Kempsell Vice President of Sales and Marketing. LSMMD is a faith-based organization created in 2018 to serve as the parent organization of continuing care retirement communities Carroll Lutheran Village (CLV), Westminster, Md., and The Lutheran Village at Miller's Grant in Ellicott City, Md.

Kempsell oversees, directs and manages LSMMD's marketing and communications efforts and leads initiatives that support the CCRC's corporate business objectives. She uses storytelling and community outreach to build awareness of both LSMMD's brand and the unique personalities of Carroll Lutheran Village and Lutheran Village at Miller's Grant. She oversees a team of six.

Kempsell joins LSMMD's executive team, led by President and CEO Jeff Branch, who was appointed in July 2019. Soon, LSMMD will roll out the new mission, vision and core values that will serve as the foundation and direct the organization's long-term strategic plan.

"We value Anne's deep industry knowledge and her proven effectiveness building strong marketing/sales teams and meeting business objectives," said Branch. "She uses the power of stories and relationship-building to further enhance our presence in the marketplace."

For almost two decades Kempsell has worked in the senior living industry. She has served in increasingly responsible leadership roles in community relations, partner services, consulting, and sales and marketing for assisted living communities, CCRCs, hospice care, and referral services throughout the United States.

Branch describes her as "an effective leader who inspires team members to work alongside one another and support one another so they can connect with our prospects and families and be of service while meeting their sales goals."

"Now is an exciting time to be part of LSMMD," said Kempsell. "A visionary CEO and board of directors are building a team that will establish our communities as trusted resources and options for senior living and care. It's an opportunity for me to make a difference in this industry."

Kempsell added, "By joining LSMMD in the middle of a pandemic, I've seen the genuine, hardworking, big-hearted heroes who are making a difference in the lives of our residents. Everyone, regardless of their official job description, helps wherever they're needed. Their dedication is powerful and I'm proud to be part of this team."

Kempsell earned a bachelor's degree in business administration from William & Mary in Williamsburg, Virginia. A resident of Pennsylvania, she most recently served as a Hospice Care Consultant in Lancaster, Pennsylvania.

SOURCE Lutheran Social Ministries of Maryland


These press releases may also interest you

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...



News published on and distributed by: